Post-Hoc: Novo’s obesity enemies

This week, Roche joined Eli Lil­ly in com­ing out against a deal that would add sig­nif­i­cant new man­u­fac­tur­ing ca­pac­i­ty to No­vo Nordisk, to help it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.